Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Monoclonal antibody neo-201 for the treatment of human carcinomas

Monoclonal antibody neo-201 for the treatment of human carcinomas

US Patent 11767367 · Granted Sep 26, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Recombinant monoclonal antibodies and corresponding antigens for colon and pancr2025
Platinum complex anti-neoplastic agents comprising a cannabinoid ligand2025
HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of u2025
Conjugate molecules2024
Methods and compositions for targeting Treg cells2024
Methods and compositions for targeting Treg cells2024
Conjugate molecules2024
HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of u2023
Recombinant monoclonal antibodies and corresponding antigens for colon and pancr2023
Humanized monoclonal antibodies and methods of use for the diagnosis and treatme2022
Development of agonist epitopes of the human papillomavirus2022
Anti-cancer antibodies, combination therapies, and uses thereof2022